VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
1 Year Est. Return
+261.03%
AUM
$216M
AUM Growth
+$39.9M
(+23%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$2.11B
| $129M | 59.53% |
4,639,304
|
|
||
|
ALMS
2
Alumis Inc
ALMS
$2.75B
| $45.1M | 20.85% |
4,619,803
|
|
||
3
Harmony Biosciences
HRMY
$1.83B
| $18.3M | 8.46% |
489,194
|
|
||
4
ALX Oncology
ALXO
$256M
| $11M | 5.07% |
9,699,925
|
|
||
5
Lyell Immunopharma
LYEL
$404M
| $10.4M | 4.81% |
337,697
-135,782
|
|
||
|
ARTV
6
Artiva Biotherapeutics
ARTV
$385M
| $2.78M | 1.29% |
648,507
-500,468
|
|